Ampicillin shortage — AU supply status & alternatives

Ampicillin

ATC J01CA01

🇦🇺 AUST R 17689 · Alphapharm Pty Ltd

In shortage · Australia

WHO Essential Medicine

IBIMICYN ampicillin

In declared shortage · 🇦🇺 Australia & also short in🇨🇦 CA🇺🇸 US

Critical shortage

Reading today’s signals…

• Can I substitute?

No pathway on record

prescriber decision required

⇄ Best alternative

None listed

refer to prescriber

◷ Expected back

June 2026

Sponsor est. via TGA — may differ by brand

Product attributes reference data we hold

Active ingredient (INN)	Ampicillin
Brand names	IBIMICYN ampicillin
ATC level 5	J01CA01
ATC level 4	J01CA
Therapeutic category	Auto-created by Therapeutic Goods Administration — Medicine Shortages scraper
WHO Essential Medicine	Yes (2023)
Controlled substance	No
Marketing-authorisation holders	KENT PHARMACEUTICALS LIMITED, CHEMIDEX PHARMA LIMITED, CRESCENT PHARMA LIMITED, CHELONIA HEALTHCARE LIMITED +6 more
Registrations on file	26
Patient information leaflet (PIL)	Not on file
Summary of product characteristics (SPC)	Not on file

Trade price 🇦🇺 Australia · awaiting price ingest

🇦🇺 AU

Ex-manufacturer

—

Dispensed (DPMQ)

—

Pack

—

Not yet captured for Australia

Official pricing isn’t on file for this market yet. PBS (Australia), NHS Drug Tariff (United Kingdom) and CMS NADAC (United States) feeds are prioritised; this panel populates automatically once the data lands.

Other markets

🇺🇸 US

US$0.44

Acquisition

Global API supply base 🇺🇸 FDA Drug Master Files · active Type II

14 API manufacturers

Manufacturers with an active Type II Drug Master File — i.e. cleared to supply this active ingredient into the US market. A proxy for how concentrated the global manufacturing base is.

Low concentration risk

Antibioticos SAFersinsa Gb SA De CvSandoz Industrial Products SAAcs Dobfar SPASandoz GMBHIstituto Biochimico Italiano Giovanni Lorenzini SPA+8 more

Manufacturing countries: Brazil, Mexico, Spain, Italy, Austria, India, China · Source: FDA List of Drug Master Files

Registration recordmarketing-authorisation holders

Registrations & marketing-authorisation holders26 registrations · 10 MA holders

Product	Strength	Form	Market	MA holder	Status
AMPICILLIN 250MG CAPSULES	250MG	capsule	🇬🇧 GB	KENT PHARMACEUTICALS LIMITED	Active
AMPICILLIN 500MG CAPSULES	500MG	capsule	🇬🇧 GB	KENT PHARMACEUTICALS LIMITED	Active
AMPICILLIN 125MG/5ML ORAL SUSPENSION	125MG	suspension	🇬🇧 GB	KENT PHARMACEUTICALS LIMITED	Active
AMPICILLIN 250MG/5ML ORAL SUSPENSION	250MG	suspension	🇬🇧 GB	KENT PHARMACEUTICALS LIMITED	Active
AMPICILLIN 500 MG POWDER FOR SOLUTION FOR INJECTION	500 MG	injection	🇬🇧 GB	CHEMIDEX PHARMA LIMITED	Active
AMPICILLIN 500MG CAPSULES	500MG	capsule	🇬🇧 GB	CHEMIDEX PHARMA LIMITED	Active
Ampicillin Capsules Bp	250MG	capsule	🇬🇧 GB	CRESCENT PHARMA LIMITED	Active
Ampicillin Capsules Bp	500MG	capsule	🇬🇧 GB	CRESCENT PHARMA LIMITED	Active
AMPICILLIN CAPSULES 250MG	250MG	capsule	🇬🇧 GB	CHELONIA HEALTHCARE LIMITED	Active
AMPICILLIN CAPSULES 500MG	500MG	capsule	🇬🇧 GB	CHELONIA HEALTHCARE LIMITED	Active
Alphacin	250mg	cap	🇦🇺 AU	Alphapharm Pty Ltd	Active
Alphacin	500mg	caphrd	🇦🇺 AU	Alphapharm Pty Ltd	Active
AUSTRAPEN ampicillin	1g	—	🇦🇺 AU	Alphapharm Pty Ltd	Active
IBIMICYN ampicillin	500mg	—	🇦🇺 AU	Juno Pharmaceuticals Pty Ltd	Active
IBIMICYN ampicillin	1g	—	🇦🇺 AU	Juno Pharmaceuticals Pty Ltd	Active

+11 more registrations on file

For health-professional reference only. Mederti aggregates shortage and substitution information from official regulatory sources. It is not clinical advice and data may be incomplete or delayed. Confirm any substitution or supply decision against the primary regulator source, the prescriber, and current clinical references (e.g. AMH) before acting. Terms.